| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/06/2002 | WO2001090334A3 Drug metabolizing enzymes |
| 06/06/2002 | WO2001090129A3 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-base compounds |
| 06/06/2002 | WO2001090068A3 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases |
| 06/06/2002 | WO2001087849A3 Modulators of tnf- alpha signaling |
| 06/06/2002 | WO2001079442A3 Albumin fusion proteins |
| 06/06/2002 | WO2001074128A3 A novel polypeptide, microtubulin 11 and the polynucleotide encoding the polypeptide |
| 06/06/2002 | WO2001068643A3 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 06/06/2002 | WO2001068614A3 5-substituted arylpyrimidines |
| 06/06/2002 | WO2001064907A3 Lipid metabolism enzymes |
| 06/06/2002 | WO2001064884A3 G12l, a gene associated with the thermal response |
| 06/06/2002 | WO2001054648A3 Treatment of disorders affecting vigilance related to myopathies |
| 06/06/2002 | WO2001044207B1 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 06/06/2002 | WO2001042225A8 4-pyrimidinyl-n-acyl-l-phenylalanines |
| 06/06/2002 | WO2001031014A3 G protein-coupled receptors expressed in human brain |
| 06/06/2002 | WO2001003684A3 Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies |
| 06/06/2002 | US20020069424 Protein-protein interactions in neurodegenerative disorders |
| 06/06/2002 | US20020068825 Polypeptide for use in the treatment of nervous system disorders |
| 06/06/2002 | US20020068756 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives |
| 06/06/2002 | US20020068752 Fused ring system containing indole as M4 selective aza-anthracene muscarinic receptor antagonists |
| 06/06/2002 | US20020068750 Mitochondria protecting agents for treating mitochondria associated diseases |
| 06/06/2002 | US20020068748 Diazabicyclooctane derivatives and therapeutic uses thereof |
| 06/06/2002 | US20020068746 Pyrrolo[2,3-d]pyrimidine compounds |
| 06/06/2002 | US20020068741 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 06/06/2002 | US20020068740 Treatment of diabetic complications such as diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, myocardial infarction, cataracts and diabetic cardiomyopathy. |
| 06/06/2002 | US20020068737 Antagonists for human alpha 1a receptors; lowering intraocular pressure; inhibiting cholesterol synthesis; relaxing lower urinary tract tissue; treatment of benign prostatic hyperplasia, impotency, cardiac arrhythmia, etc. |
| 06/06/2002 | US20020068729 Quaternary salts of substituted imidazoles, oxazoles and thiazoles |
| 06/06/2002 | US20020068723 Altering the conformational equilibrium of the A- ring to favor a chair conformation that presents the 1 alpha-hydroxyl in the axial orientation. |
| 06/06/2002 | US20020068706 Inhibitors of cyclin-dependent kinases (CDKs), particularly CDK/cyclin complexes, can be used to control proliferation and/or differentiation of cells |
| 06/06/2002 | US20020068692 Administration a melatonin blocker to patients with disorders associated with altered dopamine function; preclinical diagnosis by administering melatonin to induce a mild transient form of the disorder |
| 06/06/2002 | US20020068319 32 human secreted proteins |
| 06/06/2002 | US20020068102 Use of dietary supplement includes juice from fruit of Morinda citrifolia to scavange lipid hydroperoxides and superoxide anion free radicals within the human body |
| 06/06/2002 | US20020068058 Autoantibody inhibitors |
| 06/06/2002 | US20020068048 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues |
| 06/06/2002 | US20020068045 Such as neural progenitor cells capable of giving rise to mature somatic cells including neural cells and/or glial cells recognizable by expression of specific markers |
| 06/06/2002 | DE10060388A1 Verwendung von Pyrazolo [4,3-d]pyrimidinen Use of pyrazolo [4,3-d] pyrimidines |
| 06/06/2002 | CA2457925A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 06/06/2002 | CA2436941A1 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
| 06/06/2002 | CA2430485A1 Cytonkine receptor zcytor19 |
| 06/06/2002 | CA2430409A1 Bisubstituted carbocyclic cyclophilin binding compounds and their use |
| 06/06/2002 | CA2430311A1 Compounds active at the glucocorticoid receptor ii |
| 06/06/2002 | CA2430309A1 Combination of gaba agonists and aldose reductase inhibitors |
| 06/06/2002 | CA2430298A1 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 06/06/2002 | CA2430280A1 Substituted amino-furan-2-yl-acetic acid and amino-thien-2-yl-acetic acid derivatives and their use in the treatment of migraine and pain |
| 06/06/2002 | CA2430133A1 Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases |
| 06/06/2002 | CA2430010A1 Treatments for neurogenetic disorders, impulse control disorders, and wound healing |
| 06/06/2002 | CA2429892A1 Benzothiophene derivative compounds, process of preparation and use thereof |
| 06/06/2002 | CA2429801A1 Behavior chemotherapy |
| 06/06/2002 | CA2429615A1 Determination of risk and treatment of complications of prematurity |
| 06/06/2002 | CA2429583A1 Methylenetetrahydrofolate reductase inhibitors and use thereof |
| 06/06/2002 | CA2429469A1 Human elongase genes and uses thereof |
| 06/06/2002 | CA2429382A1 Indole-type inhibitors of p38 kinase |
| 06/06/2002 | CA2428026A1 Methods of treatment comprising administration of substance p |
| 06/06/2002 | CA2427470A1 Compositions containing an antioxidant such as alpha lipoic acid, carnitine, vitamin c or vitamin e for preventing or inhibiting loss of cognitive function |
| 06/06/2002 | CA2427161A1 Use of bisphosphonates for pain treatment |
| 06/06/2002 | CA2422729A1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 06/05/2002 | EP1211253A1 Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof and agents |
| 06/05/2002 | EP1211247A1 Acylamino cyclopropane derivatives |
| 06/05/2002 | EP1211243A1 Polymorphs of donepezil hydrochloride and process for production |
| 06/05/2002 | EP1211242A1 Prostaglandin derivatives |
| 06/05/2002 | EP1210948A1 Remedies for nervous diseases |
| 06/05/2002 | EP1210939A2 Pharmaceutical compositions comprising paracetamol and L-Cysteine or a precursor thereof |
| 06/05/2002 | EP1210605A2 Analysis and treatment of body weight and eating disorders |
| 06/05/2002 | EP1210434A2 Mammalian interleukin-12 p40 and interleukin b30. combinations thereof. antibodies. uses in pharmaceutical compositions |
| 06/05/2002 | EP1210429A2 Apoptosis proteins |
| 06/05/2002 | EP1210428A1 Pd-1, a receptor for b7-4, and uses therefor |
| 06/05/2002 | EP1210422A2 Human abc2 transporter and uses thereof |
| 06/05/2002 | EP1210419A2 Human transmembrane proteins |
| 06/05/2002 | EP1210370A1 Human tumor necrosis factor receptor tr16 |
| 06/05/2002 | EP1210344A1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 06/05/2002 | EP1210341A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 06/05/2002 | EP1210338A2 1,4-diazepine derivatives for the treatment of diseases related to the central nervous system |
| 06/05/2002 | EP1210329A2 Aminoalkoxy carbazoles and their use as 5-ht ligands |
| 06/05/2002 | EP1210328A1 Fused pyrrolecarboxamides: a new class of gaba brain receptor ligands |
| 06/05/2002 | EP1210327A2 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 06/05/2002 | EP1210326A2 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 06/05/2002 | EP1210121A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 06/05/2002 | EP1210118A2 Composition comprising a tramadol material and an anticonvulsant drug |
| 06/05/2002 | EP1210110A1 Prion protein binding proteins and uses thereof |
| 06/05/2002 | EP1210107A2 Bmp-9 compositions and methods for inducing differentiation of cholinergic neurons |
| 06/05/2002 | EP1210106A2 Methods, compositions and kits for promoting recovery from damage to the central nervous system |
| 06/05/2002 | EP1210103A1 Induced regeneration and repair of damaged neurons and nerve axon myelin |
| 06/05/2002 | EP1210100A1 Method of treating traumatic brain and spinal cord injuries and other neurogenic conditions using non-steroidal anti-inflammatory drugs and naturally occurring conotoxins |
| 06/05/2002 | EP1210090A2 Use of chemical chelators as reversal agents for drug-induced neuromuscular block |
| 06/05/2002 | EP1210087A2 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's) |
| 06/05/2002 | EP1210084A1 Pyridomorphinans, thienomoprhinans and use thereof |
| 06/05/2002 | EP1210083A2 Methods for the treatment of mental and vascular disorders |
| 06/05/2002 | EP1210081A2 Combination of active agents, said combination containing clonidine |
| 06/05/2002 | EP1210079A2 A pharmaceutical delivery system for vitamin c and vitamin e and use of a combination of vitamin c and e for preventing or treating conditions involving oxidative stress |
| 06/05/2002 | EP1210076A2 Drug therapy of the restless leg syndrome |
| 06/05/2002 | EP1210063A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 06/05/2002 | EP1209986A1 Metal-containing compositions, preparations and uses |
| 06/05/2002 | EP1109573B1 PHARMACEUTICAL COMPOSITIONS COMPRISING FACTOR XIIIa FOR NERVE HEALING |
| 06/05/2002 | EP1023273B1 Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5ht1a receptors |
| 06/05/2002 | EP0970090B1 Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use |
| 06/05/2002 | EP0934319B1 1H-PYRIDO[3,4-b]INDOLE-4-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS |
| 06/05/2002 | EP0923551B1 4-aminoethoxy indolone derivatives |
| 06/05/2002 | EP0888337B1 Piperidone tachykinin antagonists |
| 06/05/2002 | EP0883599B1 Aminotetralin derivatives and compositions and method of use thereof |
| 06/05/2002 | EP0851855B1 Acylated derivatives of melatonin and its analogues, useful as medicaments |
| 06/05/2002 | EP0840609B1 Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents |